Publication | Closed Access

78 The HCV NS3 protease inhibitor SCH 503034 in combination with PEG-IFNα-2b in the treatment of HCV-1 PEG-IFNα-2b non-responders: Antiviral activity and HCV variant analysis

Viral HepatitisAntiviral ActivityHcv-1 Peg-ifnα-2b Non-respondersImmunologyAntiviral Drug DevelopmentHepatitisVirologyAntiviral TherapyAntiviral ResponseAntiviral DrugHcv Variant AnalysisMedicine